The amyloid cascade hypothesis states that the accumulation of amyloid β (Aβ), a peptide derived from the amyloid precursor protein (APP), would initiate AD and start the pathogenesis (Selkoe 1991) and has structured research in the disease over the past 20 years, with the ultimate goal being efficient disease-modifying treatments.
